Akero Therapeutics Inc (AKRO) — Net Asset Momentum
Akero Therapeutics Inc (AKRO) recorded a net asset momentum of 40.1% as of December 2024, with net assets of $750.11 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Akero Therapeutics Inc shareholders equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Akero Therapeutics Inc Net Asset Momentum (2017–2024)
This chart tracks Akero Therapeutics Inc's year-over-year net asset growth across 8 annual reporting periods from 2017 to 2024. The most recent momentum reading is +40.1%, with net assets of $750.11 Million USD as of December 2024. For live market cap and overall valuation, see Akero Therapeutics Inc market capitalisation.
Annual Net Asset History for Akero Therapeutics Inc (2017–2024)
The table below shows the complete annual net asset history for Akero Therapeutics Inc from 2017 to 2024, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check AKRO tangible net assets ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $750.11 Million | $825.89 Million | $75.77 Million | ▲ +40.1% |
| 2023 | $535.31 Million | $580.27 Million | $44.97 Million | ▲ +63.9% |
| 2022 | $326.56 Million | $356.57 Million | $30.01 Million | ▲ +93.1% |
| 2021 | $169.11 Million | $195.55 Million | $26.44 Million | ▼ -34.6% |
| 2020 | $258.71 Million | $273.34 Million | $14.63 Million | ▲ +101.0% |
| 2019 | $128.73 Million | $138.12 Million | $9.39 Million | ▲ +357.9% |
| 2018 | $-49.92 Million | $77.15 Million | $127.07 Million | ▼ -993.8% |
| 2017 | $-4.56 Million | $658.00K | $5.22 Million | — |